Innovation for Patients
Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on discovering and developing innovative therapeutics for musculoskeletal diseases including osteoporosis, osteogenesis imperfecta, and spinal fusion. The company's pipeline features bispecific antibody candidates in Phase 2 clinical trials, with offices in Westlake Village, California and Guangzhou, China.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 2026
Dec 2024
Oct 2023
Jan 2021
Aug 2020
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
